It was found that CpG can induce much higher levels of TGF-β1 (p = 0.0485; Fig. 4e) and PDGF-B (p = 0.0037; Fig. 4f) in the cells from SLE patients than those from healthy controls. This evidence concerns the gene PDGFB and systemic lupus erythematosus.